Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810 · see citing works

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women

Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655 · see citing works

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

Dillner, J., Rebolj, M., Birembaut, P., Petry, K.-U., Szarewski, A., Munk, C., de Sanjose, S., Naucler, P., Lloveras, B., Kjaer, S., et al. (2008) · BMJ · doi:10.1136/bmj.a1754 · Cited by 629 · see citing works

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

Rijkaart, D., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W. J., Heideman, D. A. M., Kenter, G. G., Cuzick, J. M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 518 · see citing works

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

Tabrizi, S. N., Brotherton, J. M. L., Kaldor, J. M., Skinner, S. R., Liu, B., Bateson, D., McNamee, K., Garefalakis, M., Phillips, S., Cummins, E., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70841-2 · Cited by 301 · see citing works

Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

Goldhaber‐Fiebert, J. D., Stout, N. K., Salomon, J. A., Kuntz, K. M., & Goldie, S. J. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn019 · Cited by 288 · see citing works

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial

Kitchener, H. C., Gilham, C., Sargent, A., Bailey, A. C., Albrow, R., Roberts, C., Desai, M., Mather, J., Turner, A. J., Moss, S., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.008 · Cited by 175 · see citing works

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds

Kitchener, H. C., Canfell, K., Gilham, C., Sargent, A., Roberts, C., Desai, M., & Peto, J. (2014) · Health Technology Assessment · doi:10.3310/hta18230 · Cited by 152 · see citing works

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

Elfstrom, K. M., Smelov, V., Johansson, A. L. V., Eklund, C., Naucler, P., Arnheim-Dahlstrom, L., & Dillner, J. (2014) · BMJ · doi:10.1136/bmj.g130 · Cited by 142 · see citing works

Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach

Brotherton, J. M. L., Murray, S. L., Hall, M., Andrewartha, L., Banks, C., Meijer, D., Pitcher, H. C., Scully, M., & Molchanoff, L. (2013) · The Medical Journal of Australia · doi:10.5694/mja13.10272 · Cited by 141 · see citing works

Clinical Human Papillomavirus Detection Forecasts Cervical Cancer Risk in Women Over 18 Years of Follow-Up

Castle, P. E., Glass, A. G., Rush, B. B., Scott, D. R., Wentzensen, N., Gage, J. C., Buckland, J., Rydzak, G., Lorincz, A. T., & Wacholder, S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8389 · Cited by 113 · see citing works

Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV Types

Herrero, R. (2009) · The Journal of Infectious Diseases · doi:10.1086/597308 · Cited by 104 · see citing works

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus

Kim, J. J., Burger, E. A., Sy, S., & Campos, N. G. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw216 · Cited by 103 · see citing works

Fall in Genital Warts Diagnoses in the General and Indigenous Australian Population Following Implementation of a National Human Papillomavirus Vaccination Program: Analysis of Routinely Collected National Hospital Data

Smith, M. A., Liu, B. C., McIntyre, P. B., Menzies, R., Dey, A., & Canfell, K. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu370 · Cited by 83 · see citing works

Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

Burger, E. A., Ortendahl, J. D., Sy, S., Kristiansen, I. S., & Kim, J. J. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.94 · Cited by 80 · see citing works

Will cervical screening remain cost‐effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries

Simms, K. T., Smith, M. A., Lew, J., Kitchener, H. C., Castle, P. E., & Canfell, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30392 · Cited by 77 · see citing works

HPV vaccine impact in Australian women: ready for an HPV‐based screening program

Brotherton, J. M. L., Gertig, D. M., May, C. L., Chappell, G., & Saville, M. (2016) · The Medical Journal of Australia · doi:10.5694/mja15.01038 · Cited by 73 · see citing works

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

Bulkmans, N. W. J., Rozendaal, L., Voorhorst, F. J., Snijders, P. J. F., & Meijer, C. J. L. M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602541 · Cited by 66 · see citing works

Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: Independent estimates from a nationally representative mobile phone survey

Brotherton, J. M. L., Liu, B. C., Donovan, B. J., Kaldor, J. M., & Saville, M. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.11.075 · Cited by 63 · see citing works

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand

Lew, J., Simms, K. T., Smith, M. A., Lewis, H., Neal, H., & Canfell, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151619 · Cited by 56 · see citing works

Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use

Smith, M. A., Gertig, D. M., Hall, M. T., Simms, K. T., Lew, J., Malloy, M. J., Saville, M., & Canfell, K. (2016) · BMC Health Services Research · doi:10.1186/s12913-016-1375-9 · Cited by 49 · see citing works

How many cervical cancers are prevented by treatment of screen‐detected disease in young women?

Sasieni, P. D., Castañón, A., & Parkin, D. M. (2008) · International Journal of Cancer · doi:10.1002/ijc.23922 · Cited by 40 · see citing works

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia

Simms, K. T., Hall, M. T., Smith, M. A., Lew, J., Hughes, S., Yuill, S., Hammond, I. G., Saville, M., & Canfell, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0163509 · Cited by 37 · see citing works

The impact of a two- versus three-yearly cervical screening interval recommendation on cervical cancer incidence and mortality: an analysis of trends in Australia, New Zealand, and England

Simonella, L., & Canfell, K. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0250-9 · Cited by 30 · see citing works

Expenditure and resource utilisation for cervical screening in Australia

Lew, J., Howard, K., Gertig, D. M., Smith, M. A., Clements, M., Nickson, C., Shi, J., Dyer, S. M., Lord, S. J., Creighton, P., et al. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-446 · Cited by 19 · see citing works

Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis

Accetta, G., Biggeri, A., Carreras, G., Lippi, G., Carozzi, F., Confortini, M., Zappa, M., & Paci, E. (2010) · Journal of Medical Screening · doi:10.1258/jms.2010.010019 · Cited by 19 · see citing works

Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.

Fontham, E. T. H., Wolf, A. M. D., Church, T. R., Etzioni, R., Flowers, C. R., Herzig, A., Guerra, C. E., Oeffinger, K. C., Shih, Y. T., Walter, L. C., et al. (2020) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21628 · Cited by 968 · see citing works

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 943 · see citing works

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., Burger, E. A., Martin, D., Nguyen, D. T. N., Bénard, É., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30157-4 · Cited by 650 · see citing works

Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study

Simms, K. T., Steinberg, J., Caruana, M., Smith, M. A., Lew, J.-B., Soerjomataram, I., Castle, P. E., Bray, F., & Canfell, K. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30836-2 · Cited by 486 · see citing works

The projected timeframe until cervical cancer elimination in Australia: a modelling study

Hall, M. T., Simms, K. T., Lew, J., Smith, M. A., Brotherton, J. M. L., Saville, M., Frazer, I. H., & Canfell, K. (2018) · The Lancet Public Health · doi:10.1016/s2468-2667(18)30183-x · Cited by 448 · see citing works

2020 list of human papillomavirus assays suitable for primary cervical cancer screening

Arbyn, M., Simon, M., Peeters, E., Xu, L., Meijer, C. J. L. M., Berkhof, J., Cuschieri, K., Bonde, J., Ostrbenk Vanlencak, A., Zhao, F.-H., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.04.031 · Cited by 284 · see citing works

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

Palmer, T. J., Wallace, L., Pollock, K. G. J., Cuschieri, K. S., Robertson, C., Kavanagh, K., & Cruickshank, M. E. (2019) · BMJ · doi:10.1136/bmj.l1161 · Cited by 238 · see citing works

Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study

Simms, K. T., Hanley, S. J. B., Smith, M. A., Keane, A., & Canfell, K. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30010-4 · Cited by 227 · see citing works

Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)

Kyrgiou, M., Arbyn, M., Bergeron, C., Bosch, F. X., Dillner, J., Jit, M., Kim, J., Poljak, M., Nieminen, P., Sasieni, P. D., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0920-9 · Cited by 161 · see citing works

Projected time to elimination of cervical cancer in the USA: a comparative modelling study

Burger, E. A., Smith, M. A., Killen, J., Sy, S., Simms, K. T., Canfell, K., & Kim, J. J. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30006-2 · Cited by 109 · see citing works

Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population

Simms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02600-4 · Cited by 105 · see citing works

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial

Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J. M. L., Gertig, D. M., Jennett, C. J., Farnsworth, A., Tan, J., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002388 · Cited by 100 · see citing works

The use of human papillomavirus DNA methylation in cervical intraepithelial neoplasia: A systematic review and meta-analysis

Bowden, S. J., Kalliala, I. E. J., Veroniki, A. A., Arbyn, M., Mitra, A., Lathouras, K., Mirabello, L. J., Chadeau‐Hyam, M., Paraskevaidis, E. A., Flanagan, J. M., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.053 · Cited by 85 · see citing works

Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia

Hall, M. T., Simms, K. T., Lew, J., Smith, M. A., Saville, M., & Canfell, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0185332 · Cited by 77 · see citing works

Cervical Cancer Screening Postpandemic: Self-Sampling Opportunities to Accelerate the Elimination of Cervical Cancer

Ložar, T., Nagvekar, R., Rohrer, C. T., Mandishora, R. S. D., Ivanuš, U., & Fitzpatrick, M. B. (2021) · International Journal of Women s Health · doi:10.2147/ijwh.s288376 · Cited by 70 · see citing works

HPV-FRAME: a consensus statement and quality framework for modelled evaluations of HPV-related cancer control

Canfell, K., Kim, J. J., Kulasingam, S., Berkhof, J., Barnabas, R., Bogaards, J. A., Campos, N., Jennett, C., Sharma, M., Simms, K. T., et al. (2019) · Papillomavirus Research · doi:10.1016/j.pvr.2019.100184 · Cited by 68 · see citing works

Evaluation of the benefits, harms and cost‐effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia

Lew, J., John, D. J. B. S., Macrae, F., Emery, J. D., Ee, H. C., Jenkins, M. A., He, E., Grogan, P. B., Caruana, M., Sarfati, D., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31314 · Cited by 66 · see citing works

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study

Smith, M. A., Sherrah, M., Sultana, F., Castle, P. E., Arbyn, M., Gertig, D. M., Caruana, M., Wrede, C. D., Saville, M., & Canfell, K. (2022) · BMJ · doi:10.1136/bmj-2021-068582 · Cited by 59 · see citing works

Eliminating Cervical Cancer: Progress and Challenges for High-income Countries

Davies, J. C., Smith, M. A., Grover, S., Canfell, K., & Crosbie, E. J. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.06.013 · Cited by 58 · see citing works

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia

Lew, J., John, D., Macrae, F., Emery, J. D., Ee, H. C., Jenkins, M. A., He, E., Grogan, P. B., Caruana, M., Greuter, M. J. E., et al. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0128 · Cited by 56 · see citing works

Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program

Machalek, D. A., Roberts, J. M., Garland, S. M., Thurloe, J. K., Richards, A., Chambers, I., Sivertsen, T., & Farnsworth, A. (2019) · The Medical Journal of Australia · doi:10.5694/mja2.50223 · Cited by 54 · see citing works

Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America

Correa, R. M., Baena, A., Valls, J., Colucci, M. C., Mendoza, L. P., Rol, M., Wiesner, C., Ferrera, A., Fellner, M. D., González, J. V., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272205 · Cited by 55 · see citing works

Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates

Lew, J., Feletto, E., Wade, S. L., Caruana, M., Kang, Y., Nickson, C., Simms, K. T., Procopio, P., Taylor, N. J., Worthington, J., et al. (2019) · Public Health Research & Practice · doi:10.17061/phrp2921913 · Cited by 52 · see citing works

Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia

Worthington, J., Feletto, E., Lew, J., Broun, K., Durkin, S. J., Wakefield, M. A., Grogan, P. B., HARPER, T. A., & Canfell, K. (2019) · Public Health · doi:10.1016/j.puhe.2019.10.003 · Cited by 49 · see citing works

Human Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer

Piña‐Sánchez, P. (2022) · Archives of Medical Research · doi:10.1016/j.arcmed.2022.11.009 · Cited by 50 · see citing works

AACR White Paper: Shaping the Future of Cancer Prevention – A Roadmap for Advancing Science and Public Health

Lippman, S. M., Abate-Shen, C. T., Maresso, K. C., Colditz, G. A., Dannenberg, A. J., Davidson, N. E., Disis, M. L., DuBois, R. N., Szabo, E. M., Giuliano, A. R., et al. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0421 · Cited by 47 · see citing works

Laser-assisted rapid evaporative ionisation mass spectrometry (LA-REIMS) as a metabolomics platform in cervical cancer screening

Paraskevaidi, M., Cameron, S. J. S., Whelan, E., Bowden, S. J., Tzafetas, M., Mitra, A., Semertzidou, A., Athanasiou, A., Bennett, P. R., MacIntyre, D. A., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103017 · Cited by 47 · see citing works

Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China

Shen, M., Zou, Z., Bao, H., Fairley, C. K., Canfell, K., Ong, J. J., Hocking, J. S., Chow, E. P. F., Zhuang, G., Wang, L., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100726 · Cited by 44 · see citing works

Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study

Aarnio, R., Östensson, E., Olovsson, M., Gustavsson, I. M., & Gyllensten, U. B. (2020) · BMC Cancer · doi:10.1186/s12885-020-07085-9 · Cited by 48 · see citing works

Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature

Liverani, C. A., Giuseppe, J. D., Giannella, L., Carpini, G. D., & Ciavattini, A. (2020) · Journal of Oncology · doi:10.1155/2020/8887672 · Cited by 45 · see citing works

Impact of disruptions and recovery for established cervical screening programs across a range of high-income country program designs, using COVID-19 as an example: A modelled analysis

Smith, M. A., Burger, E. A., Castañón, A., de Kok, I. M. C. M., Hanley, S. J. B., Rebolj, M., Hall, M. T., Jansen, E. E. L., Killen, J., O'Farrell, X., et al. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106623 · Cited by 43 · see citing works

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort

Bonde, J. H., Bottari, F., Parvu, V., Pedersen, H., Yanson, K. A., Iacobone, A. D., Kodsi, S., Landoni, F., Vaughan, L. M., Ejegod, D. M., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32291 · Cited by 36 · see citing works

Web-Based Health Information Following the Renewal of the Cervical Screening Program in Australia: Evaluation of Readability, Understandability, and Credibility

Mac, O. A., Thayre, A., Tan, S., & Dodd, R. H. (2020) · Journal of Medical Internet Research · doi:10.2196/16701 · Cited by 35 · see citing works

High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil

Levi, J. E., Martins, T. R., Longatto‐Filho, A., Cohen, D. D., Cury, L., Fuza, L. M., Villa, L. L., & Eluf‐Neto, J. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-19-0076 · Cited by 40 · see citing works

Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection

Onuma, T., Kurokawa, T., Shinagawa, A., Chino, Y., & Yoshida, Y. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-020-01727-5 · Cited by 35 · see citing works

Detection of 14 High-Risk Human Papillomaviruses Using Digital LAMP Assays on a Self-Digitization Chip

Wang, J., Staheli, J. P., Wu, A., Kreutz, J. E., Hu, Q., Wang, J., Schneider, T., Fujimoto, B. S., Qin, Y., Yen, G. S., et al. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04973 · Cited by 35 · see citing works

Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol

Morrow, A., Hogden, E., Kang, Y., Steinberg, J., Canfell, K., Solomon, M. J., Kench, J. G., Gill, A. J., Shaw, T. J., Pachter, N., et al. (2019) · Trials · doi:10.1186/s13063-019-3457-6 · Cited by 34 · see citing works

Updated evidence-based recommendations for cervical cancer screening in France

Hamers, F. F., Poullié, A.-I., & Arbyn, M. (2021) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000701 · Cited by 34 · see citing works

Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis

Smith, M. A., Hall, M. T., Saville, M., Brotherton, J. M. L., Simms, K. T., Lew, J., Bateson, D. J., Skinner, S. R., Kelaher, M., & Canfell, K. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0998 · Cited by 33 · see citing works

Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea

Nguyen, D., Simms, K. T., Keane, A., Mola, G., Bolnga, J. W., Kuk, J., Toliman, P. J., Badman, S. G., Saville, M., Kaldor, J. M., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-007380 · Cited by 33 · see citing works

Implementation of Australia’s renewed cervical screening program: Preparedness of general practitioners and nurses

Sultana, F., Roeske, L., Malloy, M. J., McDermott, T. L., Saville, M., & Brotherton, J. M. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228042 · Cited by 33 · see citing works

Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25–69 years living in Australia

Canfell, K., Saville, M., Caruana, M., Gebski, V., Darlington-Brown, J., Brotherton, J. M. L., Heley, S., & Castle, P. E. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016700 · Cited by 30 · see citing works

The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study

Campos‐Romero, A., Anderson, K. S., Longatto‐Filho, A., Esparza, M. A. L.-R., Moran-Portela, D. D. J., Castro-Menéndez, J. A., Moreno-Camacho, J. L., Calva-Espinosa, D. Y., Acosta-Alfaro, M. A., Mejía, F. A. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-46543-8 · Cited by 30 · see citing works

The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study

Hall, M. T., Smith, M. A., Simms, K. T., Barnabas, R. V., Canfell, K., & Murray, J. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231388 · Cited by 34 · see citing works

Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study

McGregor, S., Saulo, D., Brotherton, J. M. L., Liu, B. C., Phillips, S., Skinner, S. R., Luey, M., Oliver, L., Stewart, M., Tabrizi, S. N., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.05.104 · Cited by 29 · see citing works

Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV

Hall, M. T., Simms, K. T., Murray, J. M., Keane, A., Nguyen, D. T. N., Caruana, M., Lui, G., Kelly, H. A., Eckert, L. O., Santesso, N. A., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02601-3 · Cited by 29 · see citing works

How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in A ustralia, a high vaccination coverage country

Velentzis, L. S., Caruana, M., Simms, K. T., Lew, J., Shi, J., Saville, M., Smith, M. A., Lord, S. J., Tan, J., Bateson, D. J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30926 · Cited by 26 · see citing works

Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden

Fogelberg, S., Clements, M., Pedersen, K., Sy, S., Sparén, P., Kim, J. J., & Burger, E. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239611 · Cited by 24 · see citing works

Socio-economic variations in anticipated adverse reactions to testing HPV positive: Implications for the introduction of primary HPV-based cervical screening

O’Connor, M., O’Leary, E., Waller, J., Gallagher, P., Martin, C. M., O’Leary, J. J., & Sharp, L. (2018) · Preventive Medicine · doi:10.1016/j.ypmed.2018.08.017 · Cited by 24 · see citing works

Validation of Microsimulation Models against Alternative Model Predictions and Long-Term Colorectal Cancer Incidence and Mortality Outcomes of Randomized Controlled Trials

Lew, J., Greuter, M. J. E., Caruana, M., He, E., Worthington, J., John, D. J. S., Macrae, F., Feletto, E., Coupé, V. M. H., & Canfell, K. (2020) · Medical Decision Making · doi:10.1177/0272989x20944869 · Cited by 24 · see citing works

Assessing 10-Year Safety of a Single Negative HPV Test for Cervical Cancer Screening: Evidence from FOCAL-DECADE Cohort

Gottschlich, A., van Niekerk, D., Smith, L., Gondara, L., Melnikow, J. A., Cook, D. A., Lee, M. H., Stuart, G. C. E., Martin, R. E., Peacock, S. J., et al. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1177 · Cited by 25 · see citing works

A systematic review of economic evaluations of cervical cancer screening methods

Sefuthi, T., & Nkonki, L. L. (2022) · Systematic Reviews · doi:10.1186/s13643-022-02017-z · Cited by 23 · see citing works

The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost‐effectiveness of human papillomavirus screening with self‐collection and digital registry support

Keane, A., Ng, C., Simms, K. T., Nguyen, D., Woo, Y. L., Saville, M., & Canfell, K. (2021) · International Journal of Cancer · doi:10.1002/ijc.33759 · Cited by 22 · see citing works

Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta‐analysis

Malagón, T., Volesky, K. D., Bouten, S., Laprise, C., El‐Zein, M., & Franco, E. L. (2020) · International Journal of Cancer · doi:10.1002/ijc.33035 · Cited by 23 · see citing works

Psychosocial impact of testing human papillomavirus positive in Australia's human papillomavirus‐based cervical screening program: A cross‐sectional survey

Chadwick, V. L., Bennett, K. F., McCaffery, K. J., Brotherton, J. M. L., & Dodd, R. H. (2022) · Psycho-Oncology · doi:10.1002/pon.5897 · Cited by 21 · see citing works

Factors associated with cervical cancer screening utilisation by people with physical disabilities: A systematic review

Chan, D. N. S., Law, B. M. H., So, W. K. W., & Fan, N. (2022) · Health Policy · doi:10.1016/j.healthpol.2022.08.003 · Cited by 21 · see citing works

Prevalence of multiple human papillomavirus infections and association with cervical lesions among outpatients in Fujian, China: A cross‐sectional study

Chen, Y., Li, S., Zheng, J., Xue, H., Chen, J., & Zheng, X. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28062 · Cited by 21 · see citing works

Spotlight on the role of human papillomavirus vaccines

Bogani, G., Raspagliesi, F., Donato, V. D., Brusadelli, C., Guerrisi, R., Pinelli, C., Casarin, J., Ghezzi, F., Fabro, A. D., Ditto, A., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.08.034 · Cited by 21 · see citing works

Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening Guidelines

Pedersen, K., Kristiansen, I. S., Sy, S., Kim, J. J., & Burger, E. A. (2023) · Value in Health · doi:10.1016/j.jval.2023.04.005 · Cited by 20 · see citing works

A retrospective analysis of human papillomavirus (HPV) prevalence and genotype distribution among 25,238 women in Shanghai, China revealed the limitations of current HPV-based screening and HPV vaccine

Ruan, Y., Li, H., Liu, M., Cao, G., Xu, X., Han, L., & Li, F. (2023) · Cancer Epidemiology · doi:10.1016/j.canep.2023.102372 · Cited by 20 · see citing works

Digital CRISPR-Powered Biosensor Concept without Target Amplification Using Single-Impact Electrochemistry

Freko, S., Nikić, M., Mayer, D., Weiß, L. J. K., Simmel, F. C., & Wolfrum, B. L. (2024) · ACS Sensors · doi:10.1021/acssensors.4c02060 · Cited by 20 · see citing works

Current Status of and Perspectives on Cervical Cancer Screening in Korea

Lim, S., & Yoo, C. W. (2019) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2019.04.11 · Cited by 19 · see citing works

Spatial and temporal variations in cervical cancer screening participation among indigenous and non-indigenous women, Queensland, Australia, 2008–2017

Dasgupta, P., Aitken, J. F., Condon, J. R., Garvey, G., Whop, L. J., DeBats, C., & Baade, P. D. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101849 · Cited by 19 · see citing works

Health care provider perspectives on cervical screening for Aboriginal and Torres Strait Islander women: a qualitative study

Jaenke, R., Butler, T., Condon, J. R., Garvey, G., Brotherton, J. M. L., Cunningham, J., Anderson, K. M., Tong, A., Moore, S., & Whop, L. J. (2021) · Australian and New Zealand Journal of Public Health · doi:10.1111/1753-6405.13084 · Cited by 17 · see citing works

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer

Inturrisi, F., Lissenberg-Witte, B. I., Veldhuijzen, N. J., Bogaards, J. A., Ronco, G., Meijer, C. J. L. M., & Berkhof, J. H. (2020) · International Journal of Cancer · doi:10.1002/ijc.33207 · Cited by 16 · see citing works

Australian National Cervical Screening Program renewal: Attitudes and experiences of general practitioners, and obstetricians and gynaecologists

Obermair, H., Bennett, K. F., Brotherton, J. M. L., Smith, M. A., McCaffery, K. J., & Dodd, R. H. (2021) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13310 · Cited by 17 · see citing works

Cervical cancer: Challenges and prevention strategies: A narrative review

Tsige, A. W., & Beyene, D. A. (2024) · Health Science Reports · doi:10.1002/hsr2.2149 · Cited by 16 · see citing works

Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia

Velentzis, L. S., Smith, M. A., Simms, K. T., Lew, J., Hall, M. T., Hughes, S., Yuill, S., Killen, J., Keane, A., Butler, K. A., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.12.019 · Cited by 16 · see citing works

Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing–Based Cervical Screen-and-Treat Program in El Salvador

Alfaro, K. M., Maza, M., Felix, J. C., Gage, J. C., Castle, P. E., Alonzo, T. A., Chacón, A., González, E., Soler, M., Rodriguez, G. C., et al. (2020) · JCO Global Oncology · doi:10.1200/go.20.00206 · Cited by 16 · see citing works

Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece

Skroumpelos, A., Αγοραστός, Θ., Constantinidis, T. C., Chatzistamatiou, Κ., & Kyriopoulos, J. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226335 · Cited by 16 · see citing works

Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis

Choi, C., Leung, K. S. M., Chan, K. K. L., Bai, Y., Jit, M., & Wu, J. T. K. (2023) · BMC Medicine · doi:10.1186/s12916-023-02748-3 · Cited by 15 · see citing works

Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women

Ma, X., Harripersaud, K., Smith, M. K., Fairley, C. K., Zou, H., Zou, Z., Wang, Y., Zhuang, G., & Zhang, L. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1832835 · Cited by 15 · see citing works

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial

Cromwell, I., Smith, L., van der Hoek, K., Hedden, L., Coldman, A. J., Cook, D. A., Franco, E. L., Krajden, M., Martin, R. E., Lee, M. H., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3864 · Cited by 15 · see citing works

Effect of introducing human papillomavirus genotyping into real-world screening on cervical cancer screening in China: a retrospective population-based cohort study

Dong, B., Zou, H., Mao, X., Su, Y., Gao, H., Xie, F., Lv, Y., Chen, Y., Kang, Y., Xue, H., et al. (2021) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359211010939 · Cited by 15 · see citing works

Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples

Terada, N., Matsuura, M., Kurokawa, S., Nishimura, Y., Tamate, M., Isoyama, K., Yamazaki, S., Shimada, H., Suzuki, M., Tabuchi, Y., et al. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02238-1 · Cited by 14 · see citing works

Developing HPV Vaccination Communication Strategies: Assessing Knowledge, Attitudes, and Barriers Among Healthcare Professionals in Kazakhstan

Kassymbekova, F., Rommel, A., Kaidarova, D., Auyezova, A. M., Nukusheva, S., Dunenova, G., Bolatbekova, R., Жетписбаева, И. А., Abdushukurova, G., & Glushkova, N. (2024) · Vaccines · doi:10.3390/vaccines12111225 · Cited by 13 · see citing works

The socioeconomic burden of cervical cancer and its implications for strategies required to achieve the WHO elimination targets

Brotherton, J. M. L., Vajdic, C. M., & Nightingale, C. E. (2025) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2025.2451732 · Cited by 14 · see citing works

Evaluation of p16 in Epithelial Ovarian Cancer for a 10-Year Study in Northeast China: Significance of HPV in Correlation with PD-L1 Expression

Yang, X., You, Q., Yao, G., Geng, J., Ma, R., & Meng, H. (2020) · Cancer Management and Research · doi:10.2147/cmar.s262678 · Cited by 13 · see citing works

Implementing changes to cervical screening: A qualitative study with health professionals

Dodd, R. H., Obermair, H., & McCaffery, K. J. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13200 · Cited by 13 · see citing works

Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies

de Bondt, D. D., Naslazi, E., Jansen, E. E. L., Kupets, R., McCurdy, B. R., Stogios, C., de Kok, I. M. C. M., & Hontelez, J. A. C. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.03.008 · Cited by 12 · see citing works

Prevalence and Genotype Distribution of High-Risk HPV Genotypes Among Women in Greece: A Retrospective Analysis of 3500 Women

Tsakogiannis, D., Zografos, E., Tzioga, L., Zografos, C. G., Zagouri, F., & Bletsa, G. (2025) · Cancers · doi:10.3390/cancers17081267 · Cited by 14 · see citing works

Cervical screening in HPV-vaccinated populations

Canfell, K. (2018) · Climacteric · doi:10.1080/13697137.2018.1428296 · Cited by 12 · see citing works

Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment services

Hall, M. T., Hyatt, A., Smith, M. A., Torode, J., Costa, T., Nguyen, D., Balshaw, T., Grogan, P. B., Sweeny, K., Auste, C., et al. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101423 · Cited by 13 · see citing works

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study

Brotherton, J. M. L., McDermott, T. L., Smith, M. A., Machalek, D. A., Shilling, H. S., Prang, K.-H., Jennett, C. J., Nightingale, C. E., Zammit, C. M., Pagotto, A., et al. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102213 · Cited by 11 · see citing works

Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management

Bowden, S. J., Ellis, L. B., Kalliala, I. E. J., Paraskevaidi, M., Tighe, J., Kechagias, K. S., Doulgeraki, T., Paraskevaidis, E. A., Arbyn, M., Flanagan, J. M., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-071534 · Cited by 11 · see citing works

Recent Advances in HPV Detection: From Traditional Methods to Nanotechnology and the Application of Quantum Dots

He, Z., Zheng, X., Liu, R., Zhao, K., Mao, D., Zhang, L., Wan, R., Zhang, H., & Wang, X. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s524518 · Cited by 12 · see citing works

Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand

Smith, M. A., Hall, M. T., Lew, J., & Canfell, K. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.063 · Cited by 12 · see citing works

Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study

Martellucci, C. A., Morettini, M., Brotherton, J. M. L., Canfell, K., Manzoli, L., Flacco, M. E., Palmer, M., Rossi, P. G., Martellucci, M., Giacomini, G., et al. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0895 · Cited by 11 · see citing works

A new era for cervical screening in Australia: Watch this space!

Hammond, I. G., Canfell, K., & Saville, M. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12669 · Cited by 11 · see citing works

Multiplex single-cell droplet PCR with machine learning for detection of high-risk human papillomaviruses

Huang, Y., Sun, L., Liu, W., Yang, L., Song, Z., Ning, X., Li, W., Tan, M., Yu, Y., & Li, Z. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341050 · Cited by 11 · see citing works

The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications

Hall, M. T., Smith, M. A., Lew, J., O’Hallahan, J., Fentiman, G., Neal, H., Sage, M., & Canfell, K. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.045 · Cited by 12 · see citing works

Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia

Feletto, E., Lew, J., Worthington, J., He, E., Caruana, M., Butler, K. A., Hui, H., Taylor, N. J., Banks, E., Barclay, K., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036475 · Cited by 10 · see citing works

Ensuring quality in cervical screening programmes based on molecular human papillomavirus testing

Cuschieri, K. S., Schuurman, R., & Coughlan, S. (2019) · Cytopathology · doi:10.1111/cyt.12679 · Cited by 10 · see citing works

Health economic evaluation of primary human papillomavirus screening in urban populations in China

Keane, A., Shi, J., Simms, K. T., Liu, Y., Lew, J., Mazariego, C. G., Yuill, S., Wu, R., Liu, Z., Zhao, F., et al. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101861 · Cited by 10 · see citing works

Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2–3 in Thai women infected with high-risk types of human papillomavirus

Srisuttayasathien, M., Kantathavorn, N., Luasiripanthu, T., Petchjorm, S., Samrarn, J., Ittiamornlert, P., Krisorakun, W., Vanichtantikul, A., Wetcho, T., & Saeloo, S. (2024) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2024.01.014 · Cited by 9 · see citing works

Self‐collection for HPV screening: a game changer in the elimination of cervical cancer

Canfell, K., Smith, M. A., & Bateson, D. J. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51262 · Cited by 9 · see citing works

Clinician practices, knowledge, and attitudes regarding primary human papillomavirus testing for cervical cancer screening: A mixed-methods study in Indiana

Rodriguez, N. M., Brennan, L. P., Claure, L. A., Balian, L. N., Kasting, M. L., Champion, V. L., & Forman, M. R. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.102070 · Cited by 8 · see citing works

Meta-analysis of downregulated E-cadherin as a diagnostic biomarker for cervical cancer

Ma, X., Ge, A., Han, J., Kang, J., Zhang, Y., Liu, X., Xing, L., Liu, X., & Dong, L. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06475-7 · Cited by 8 · see citing works

Should Cervical Cancer Screening be Performed Before the Age of 25 Years?

Moscicki, A., Perkins, R. B., Saville, M., & Brotherton, J. M. L. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000434 · Cited by 7 · see citing works

Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial

Hu, S., Kreimer, A. R., Porras, C., Guillén, D., Alfaro, M., Darragh, T. M., Stoler, M. H., Villegas, L. F., Ocampo, R., Rodríguez, A. C., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac107 · Cited by 7 · see citing works

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand

Lew, J., Simms, K. T., Smith, M. A., Lewis, H., Neal, H., & Canfell, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151619 · Cited by 56 · see citing works

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia

Simms, K. T., Hall, M. T., Smith, M. A., Lew, J., Hughes, S., Yuill, S., Hammond, I. G., Saville, M., & Canfell, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0163509 · Cited by 37 · see citing works

Cost-effectiveness estimates: the need for complete reporting – Authors' reply

Lew, J., Simms, K. T., Smith, M. A., Saville, M., Hammond, I. G., & Canfell, K. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30076-2 · Cited by 2 · see citing works

National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study

Smith, M. A., Sherrah, M., Sultana, F., Castle, P. E., Arbyn, M., Gertig, D. M., Caruana, M., Wrede, C. D., Saville, M., & Canfell, K. (2022) · BMJ · doi:10.1136/bmj-2021-068582 · Cited by 59 · see citing works

Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece

Skroumpelos, A., Αγοραστός, Θ., Constantinidis, T. C., Chatzistamatiou, Κ., & Kyriopoulos, J. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226335 · Cited by 16 · see citing works